Mundipharma (China) Pharmaceutical Co. Ltd clinical trials
A country office of Mundipharma
The registry lists 19 studies whose lead sponsor is Mundipharma (China) Pharmaceutical Co. Ltd. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 13, 2026.
Registry sponsor names on this page
- Mundipharma (China) Pharmaceutical Co. Ltd19 studies
Something wrong with this grouping? Tell us on the Mundipharma page.
Studies
Recruiting first, then most recently updated. Showing 19 of 19. All Mundipharma studies →
- Real-world Study of the Effectiveness and Tolerability of Outpatient Titration of OxyContin for the Moderate and Severe Pain in Cancer PatientsNot yet recruitingNCT07869797
Sponsor listed in the registry: Mundipharma (China) Pharmaceutical Co. Ltd
- OTR Tablet 10 mg Fasted-state Bioequivalence StudyCompletedNCT03403504Phase 1
Sponsor listed in the registry: Mundipharma (China) Pharmaceutical Co. Ltd
- OTR Tablet 40 mg Fasted-state Bioequivalence StudyCompletedNCT03398278Phase 1
Sponsor listed in the registry: Mundipharma (China) Pharmaceutical Co. Ltd
- OTR Tablet 40 mg Fed-state Bioequivalence StudyCompletedNCT03398330Phase 1
Sponsor listed in the registry: Mundipharma (China) Pharmaceutical Co. Ltd
- OxyNorm® Capsules (Immediate-Release) Pharmacokinetic (PK) StudyCompletedNCT01643772Phase 1
Sponsor listed in the registry: Mundipharma (China) Pharmaceutical Co. Ltd
- Determine the Safety and Efficacy of Oxy/Nal Tablets Compared to Oxy PR in Subjects With Cancer PainCompletedNCT01885182Phase 3
Sponsor listed in the registry: Mundipharma (China) Pharmaceutical Co. Ltd
- A Single Arm Study Evaluating the Efficacy and Safety of Pralatrexate in Subjects With Relapsed or Refractory PTCLCompletedNCT03349333Phase 3
Sponsor listed in the registry: Mundipharma (China) Pharmaceutical Co. Ltd
- OXN PR Tablet 5/2.5 mg and20/10 mg PK Study in Chinese Moderate to Severe Chronic Non-malignant PatientsCompletedNCT02880475Phase 1
Sponsor listed in the registry: Mundipharma (China) Pharmaceutical Co. Ltd
- A Study to Evaluate Buprenorphine Transdermal Patch in Chinese Subjects With Moderate to Severe Chronic Cancer PainStatus unknownNCT03967327Phase 3
Sponsor listed in the registry: Mundipharma (China) Pharmaceutical Co. Ltd
- Buprenorphine Transdermal Patches Pharmacokinetic StudyStatus unknownNCT03975010Phase 1
Sponsor listed in the registry: Mundipharma (China) Pharmaceutical Co. Ltd
- Efficacy of FLUTIFORM ® vs Seretide® in Moderate to Severe Persistent Asthma in Subjects Aged ≥12 YearsStatus unknownNCT03387241Phase 3
Sponsor listed in the registry: Mundipharma (China) Pharmaceutical Co. Ltd
- Immediate-Release Oxycodone Capsules Study in Cancer PainCompletedNCT01675622Phase 3
Sponsor listed in the registry: Mundipharma (China) Pharmaceutical Co. Ltd
- OxyNorm Capsules in Post-Operative Pain StudyCompletedNCT01675635Phase 3
Sponsor listed in the registry: Mundipharma (China) Pharmaceutical Co. Ltd
- Efficacy and Safety of 5% Lidocaine Patch With Placebo Patch in Subjects With Herpes Zoster Associated PainCompletedNCT02452112Phase 2/3
Sponsor listed in the registry: Mundipharma (China) Pharmaceutical Co. Ltd
- Targin for Non-cancer PainCompletedNCT01918098Phase 3
Sponsor listed in the registry: Mundipharma (China) Pharmaceutical Co. Ltd
- Pharmacokinetic (PK) Study of OxyNorm Injections in Chinese PatientCompletedNCT01482936Phase 1
Sponsor listed in the registry: Mundipharma (China) Pharmaceutical Co. Ltd
- Oxycodone Hydrochloride Injection in the Postoperative Pain Relieving TreatmentCompletedNCT01304134Phase 3
Sponsor listed in the registry: Mundipharma (China) Pharmaceutical Co. Ltd
- NORSPAN Transdermal Patches Phase III Study In Non-Cancer PainCompletedNCT01476774Phase 3
Sponsor listed in the registry: Mundipharma (China) Pharmaceutical Co. Ltd
- Norspan Transdermal Patches Study in Osteoarthritis PatientsCompletedNCT01643759Phase 1
Sponsor listed in the registry: Mundipharma (China) Pharmaceutical Co. Ltd